Openbookopenbook
Equity
Siegfried Holding AG(SGFEF)
USD --+0.00%
Reward40Moderate
Risk38Moderate
📊75%Data
SGFEF
+0.0 · +0.00%
USD · PINK
Siegfried Holding AG | Healthcare
Value Trap
Market Cap:5.32Bn
ℹ️
Reward Rating
40
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
38
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on SGFEF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Siegfried Holding AG?

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

SGFEF · Verdict

Moderate reward · moderate risk

SGFEF's standout is cash flow; growth and profitability weigh on the picture.

Based on 88% data coverage

SGFEF · Verdict

What’s working & what to watch

Strengths 1

  • Cash flow71/100

    1% free-cash-flow margin

Watchouts 3

  • Growth33/100

    Rev +2.6% CAGR · earnings +2.5%

  • Profitability35/100

    13% net margin · 16% ROE

  • Valuation45/100

    P/E 19.5× · PEG 2.29

Model-based scoring. For information only — not financial advice.

What is Siegfried Holding AG?

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 5.32B, and a P/E ratio of 23.5x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Discount reflects uncertainty around future performance.

OpenBook Logo Analysis

Reward: Moderate (40)

The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap5.32B
P/E Ratio23.5079
Dividend Yield0.38%
52 Week High114.35
52 Week Low92.9224
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding44M
No. of Employees3,891
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta0.801
CurrencyUSD
Websitewww.siegfried.ch
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.